Detalhe da pesquisa
1.
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
PLoS Med
; 16(4): e1002790, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31039172
2.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25629663
3.
Optimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.
J Infect Dis
; 213(5): 824-30, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26450421
4.
Use of Novel National Data Sets to Monitor Chemotherapy Use and Outcomes: A Retrospective Cohort Study of Non-Small-Cell Lung Cancer in Aotearoa New Zealand.
JCO Oncol Pract
; 20(3): 401-408, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38206292
5.
Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study.
Lancet Reg Health West Pac
; 24: 100522, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35832510
6.
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Vaccine
; 38(4): 779-789, 2020 01 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31735500
7.
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Vaccine
; 34(11): 1412-21, 2016 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26854906
8.
A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults.
PLoS One
; 10(11): e0141687, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26529238